SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,339,000 | -23.9% | 121,504 | -8.4% | 0.25% | -17.2% |
| Q2 2019 | $4,388,000 | -15.9% | 132,607 | -11.0% | 0.30% | -8.7% |
| Q1 2019 | $5,220,000 | +7.1% | 148,974 | +1.5% | 0.33% | -5.4% |
| Q4 2018 | $4,875,000 | -40.9% | 146,739 | -10.5% | 0.35% | -23.0% |
| Q3 2018 | $8,255,000 | -23.9% | 163,956 | -9.6% | 0.46% | -25.9% |
| Q2 2018 | $10,850,000 | +18.4% | 181,283 | -9.4% | 0.62% | +21.1% |
| Q1 2018 | $9,162,000 | -11.8% | 200,042 | -23.3% | 0.51% | +2.4% |
| Q4 2017 | $10,388,000 | +48.8% | 260,676 | +49.3% | 0.50% | +74.6% |
| Q3 2017 | $6,983,000 | – | 174,572 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |